Â鶹ÊÓƵ

The spread and duration of the pandemic is having a profound effect on the pharma industry, both in terms of performance and long-term strategic planning

We have seen a relative recovery in listing numbers through Q3, with a number of 'big-ticket' candidates waiting in the wings

Gold producers could benefit if the BoE takes a more laissez-faire line on inflation

The group continues to enhance its ESG credentials, but dividend support remains central to the investment case

The collapse in civil aviation activity could reignite speculation about a merger with the UK's biggest defence contractor

With rising job losses, index values may finally start to reflect the wider economy

The experience of the 'Sunshine State' highlights the difficulty of transitioning to clean energy on a grand scale

If the energy major thinks demand for its key product may have already peaked, there can be no question of its choice to pivot

Investors intent on tapping into the growth of electric motoring may be looking at the wrong technology

The world's biggest bricks-and-mortar retailer appears to have the world's biggest online retailer in its sights – or is it a case of damage limitation?